Literature DB >> 1328351

Inhibitory effect of dexamethasone on the oxytocin response to insulin-induced hypoglycemia in normal men.

P Chiodera1, R Volpi, A Caiazza, C Davoli, C Marchesi, C Papadia, L Capretti, R Bocchi, V Coiro.   

Abstract

Glucocorticoids are known to reduce both ACTH and arginine vasopressin responses to insulin-induced hypoglycemia in normal men. The present study was undertaken in order to establish whether glucocorticoids are capable of modifying the oxytocin (OT) response to hypoglycemia. For this purpose, 8 normal men (28-33 yr) were tested with insulin (0.15 IU/kg in an iv bolus) [insulin tolerance test (ITT)] with and without pretreatment with dexamethasone (2 or 4 mg in an iv bolus 10 min before insulin). Eight different subjects (29-35 yr) were tested with dexamethasone alone. The administration of dexamethasone (2 or 4 mg) alone changed neither ACTH nor OT concentrations in the plasma during the next hour. Insulin produced similar hypoglycemic responses, regardless of dexamethasone treatment. ACTH levels rose significantly in response to insulin-induced hypoglycemia, with a mean peak response at 45 min (p less than 0.01 vs baseline). Two and four mg dexamethasone produced similar significant reductions of the ACTH response to hypoglycemia (p less than 0.02 at 45 min, p less than 0.05 at 30 and 60 min vs ITT). In the ITT, OT levels rose significantly in response to hypoglycemia, with a mean peak response at 45 min (p less than 0.01 vs basal value). The pretreatment with 2 or 4 mg dexamethasone reduced in a similar manner the hypoglycemia-induced OT rise (p less than 0.05 at 30 and 45 min vs ITT). These findings show a partial inhibition by dexamethasone of the OT response to hypoglycemia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328351     DOI: 10.1007/BF03348773

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  Control of canine ACTH by corticosteroids: interaction between dose and time.

Authors:  M Keller-Wood
Journal:  Am J Physiol       Date:  1988-01

2.  Effects of corticosterone on the secretion of corticotrophin-releasing factor, arginine vasopressin and oxytocin into hypophysial portal blood in long-term hypophysectomized rats.

Authors:  W J Sheward; G Fink
Journal:  J Endocrinol       Date:  1991-04       Impact factor: 4.286

Review 3.  Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor.

Authors:  F A Antoni
Journal:  Endocr Rev       Date:  1986-11       Impact factor: 19.871

4.  Hypothalamic integration: organization of the paraventricular and supraoptic nuclei.

Authors:  L W Swanson; P E Sawchenko
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

5.  Pharmacological doses of oxytocin affect plasma hormone levels modulating glucose homeostasis in normal man.

Authors:  G Paolisso; S Sgambato; N Passariello; R Torella; D Giugliano; S Mignano; M Varricchio; F D'Onofrio
Journal:  Horm Res       Date:  1988

6.  Glucocorticoids regulate ovine hypophysial portal levels of corticotropin-releasing factor and arginine vasopressin in a stress-specific manner.

Authors:  B J Canny; J W Funder; I J Clarke
Journal:  Endocrinology       Date:  1989-11       Impact factor: 4.736

7.  Immunoreactive vasopressin and oxytocin in hypothalamo-hypophysial portal blood of the Brattleboro and Long-Evans rat: effect of adrenalectomy and dexamethasone.

Authors:  D J Eckland; K Todd; S L Lightman
Journal:  J Endocrinol       Date:  1988-04       Impact factor: 4.286

8.  Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia.

Authors:  P M Plotsky; T O Bruhn; W Vale
Journal:  Endocrinology       Date:  1985-07       Impact factor: 4.736

9.  Human corticotropin (ACTH) radioimmunoassay with synthetic 1--24 ACTH.

Authors:  P C Kao; N S Jiang; P C Carpenter
Journal:  Clin Chem       Date:  1979-07       Impact factor: 8.327

10.  Corticotrophin releasing hormone (CRH1-41) stimulates the secretion of adrenocorticotrophin, vasopressin and oxytocin but not adrenocorticotrophin precursors: evidence from petrosal sinus sampling in man.

Authors:  S S Nussey; S R Page; D B Peterson; J Byrne; S R Crosby; A White; V T Ang; R Jackson; J S Jenkins
Journal:  Clin Endocrinol (Oxf)       Date:  1991-01       Impact factor: 3.478

View more
  1 in total

1.  Impact of recurring intermediate insulin-induced hypoglycemia on hypothalamic paraventricular corticotropin-releasing hormone, oxytocin, vasopressin and glucokinase gene profiles: role of type II glucocorticoid receptors.

Authors:  Karen P Briski; Ajay Y Kale; Kamlesh V Vavaiya
Journal:  Exp Brain Res       Date:  2009-05-06       Impact factor: 1.972

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.